On January 7, 2016, Miyanaga, Wataru; Kawahira, Mizuki; Matsumoto, Kayo; Nakagawa, Tadakiyo; Tokumasu, Munetaka; Takeshita, Sen published a patent.SDS of cas: 1162054-86-5 The title of the patent was Preparation of heterocyclic amidocarboxylic acid compounds as glycogen synthase activators and pharmaceutical compositions containing them. And the patent contained the following:
The purpose of the present invention is to provide a novel compound that is capable of activating glycogen synthase but hardly activates receptor PPAR and shows high safety. Provided is a compound represented by general formula I (all variables are defined in the specification) or a pharmaceutically acceptable salt thereof. Thus, 2-[[5-[[4-(4,5-difluoro-2-methylsulfanylphenyl)phenoxy]methyl]furan-2-carbonyl]-(2-methoxyethyl)amino]acetic acid (preparation given) activated human glycogen synthase with EC50 <0.003 渭M. The experimental process involved the reaction of (S)-1-Methoxypropan-2-amine hydrochloride(cas: 1162054-86-5).SDS of cas: 1162054-86-5
The Article related to heterocyclic amidocarboxylic acid compound glycogen synthase activator treatment diabetes, phenylphenoxymethylfuranecaraboxamidoacetic acid preparation glycogen synthase activator and other aspects.SDS of cas: 1162054-86-5
Referemce:
Ether – Wikipedia,
Ether | (C2H5)2O – PubChem